George Washington University to participate in Sanofi COVID-19 vaccine trial

(George Washington University) The George Washington University is a site for a phase 2 clinical trial for Sanofi's adjuvanted recombinant protein-based COVID-19 vaccine candidate.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news